Skip to main content

FRACTYL HEALTH, INC.

جودة البيانات: 83%
GUTS
NASDAQ Manufacturing Measuring & Analyzing Instruments
KWD 0.51
KWD 0.00 (0.00%)
6 months return
Momentum
Neutral
Free cash flow
-90.89 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-112.67%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio4.27
Interest CoverageN/A

التقييم

PE (TTM|NTM)
-0.51 | -0.81
أعلى من متوسط القطاع (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -90.89 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

5 محللين
Buy
+930.1%
upside to target
الحالي
KWD 0.51
Consensus Target
KWD 5.24
KWD 2.00
أدنى
KWD 8.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-0.81
ربحية السهم المستقبلية
-KWD 0.57
الإيرادات المقدّرة
29.77 M

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.16 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.49 -KWD 0.57 -KWD 0.71 -KWD 0.07
Estimate -KWD 0.50 -KWD 0.36 -KWD 0.32 -KWD 0.18 -KWD 0.16 -KWD 0.16
المفاجأة +2.00% -58.33% -124.68% +61.11%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -140.95 M
ROE N/A ROA -159.92%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -90.89 M
ROIC -112.67% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 4.27
Debt / Equity N/A Current Ratio 4.27
Interest Coverage N/A Asset Turnover N/A
Working Capital 61.02 M Tangible Book Value -3.18 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.51 · EV/EBITDA: N/A
P/E Ratio -0.51 Forward P/E -0.81
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2.44 Fwd Earnings Yield N/A
FCF Yield -125.35%
Market Cap 72.50 M Enterprise Value -5.15 M

Per Share

EPS: -1.86 · FCF/Share: -0.57
EPS (Diluted TTM) -1.86 Revenue / Share N/A
FCF / Share -0.57 OCF / Share -0.57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 64.48% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 64.48%
SBC-Adj. FCF -100.93 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue
Net Income -140.95 M -68.69 M
EPS (Diluted) -1.86 -1.62
Gross Profit 43,000.0 43,000.0
Operating Income -96.82 M -93.53 M
EBITDA
R&D Expenses 74.54 M 70.47 M
SG&A Expenses 22.28 M 23.10 M
D&A
Interest Expense
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 121.40 M 108.08 M
Total Liabilities 111.94 M 79.65 M
Shareholders' Equity 9.46 M 28.42 M
Total Debt
Cash & Equivalents 81.54 M 67.46 M
Current Assets 87.58 M 71.76 M
Current Liabilities 18.33 M 19.78 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -0.5 -1.5
P/B 1.6
ROE % -54.7
Net Margin % -41.5
Rev Growth 5Y % 1.7
D/E 0.3

ETFs Holding This Stock

BRSIX BRSIX
0.08% weight